Biovet
Biovet S.A. is a Spanish manufacturer of natural feed additives for animal nutrition, founded in 1984 and headquartered in Tarragona. It develops patented mycotoxin binders, natural preservatives, and pronutrient additives sold globally through distributors serving poultry, swine, ruminant, aquaculture, and pet segments.
- Company typePrivate
- Founded1984
- HeadquartersTarragona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biovet does
Biovet S.A. is a Spanish specialty manufacturer of natural feed additives for animal nutrition, founded in 1984 by a team of veterinarians and chemists and headquartered in Constantí, Tarragona, Spain. The company develops and markets a portfolio of proprietary products organized around three core technology platforms: (1) Silicoglycidol, a patented mycotoxin binder molecule granted in 1988 and effective at 0.5 kg/t inclusion rate against multiple mycotoxin groups; (2) the Cimenol Ring antimicrobial technology used in Alquermold Natural preservatives, providing dual-action feed preservation and intestinal pathogen control; and (3) the Alquernat pronutrient line, based on botanical extracts that modulate intestinal physiology and local immunity, deployed across multiple species. Complementary products include digestive efficiency additives (Alquerfeed Diatom), ammonia reducers (Alquernat Yucca), liver support, and vitamin/amino-acid supplements.
The company's go-to-market is sales-led and event-driven, combining a direct veterinary technical team with regional distributors across South and Central America, North America, Europe, Asia, the Middle East, and Africa. Pricing follows a unit-pricing model tied to inclusion rate (per kg per ton of feed or per ml per liter of drinking water), with no public price disclosure. The customer base spans feed mills, poultry and swine integrators, dairy and beef producers, aquaculture operations, and pet owners, served through six animal-species-segmented product lines plus a dedicated pets category. Biovet holds FAMI-QS certification, three granted patents (Silicoglycidol, Cimenol Ring, in-vitro digestive simulation), and runs an annual international symposium in Tarragona that alternates with Americas/Asia venues. The company maintains R&D collaborations with the University of Helsinki, Universidad Científica del Sur (Peru), and other European, US, and Asian universities for product validation.
Biovet firmographics
Firmographics- Name
- Biovet
- Legal name
- Biovet, S.A.
- Website
- https://biovet-alquermes.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biovet S.A. is a Spanish manufacturer of natural feed additives for animal nutrition, founded in 1984 and headquartered in Tarragona. It develops patented mycotoxin binders, natural preservatives, and pronutrient additives sold globally through distributors serving poultry, swine, ruminant, aquaculture, and pet segments.
- Ownership category
- akta.pro rank
Biovet industry classification
Industry- Product category
- Animal Feed Additives
- NAICS
- Other Animal Food Manufacturing (311119)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Mycotoxin Risk Management (Binders, Deactivators) (AFADAKAG)
- akta.pro secondary industries
- Additive & Premix Integration Services (enzymes, probiotics, minerals/vitamins, medication where permitted) (AFADAMAF), Phytogenics & Botanicals (Essential Oils, Plant Extracts) (AFADAKAF), Feed Additives & Medicated Feed (Coccidiostats, Ionophores, Antibiotic Alternatives) (HLAMAHAI)
Keywords
Where Biovet is headquartered
LocationHeadquarters
- HQ city
- Tarragona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Biovet business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Natural Feed Additives - Product Sales: Biovet manufactures and sells natural feed additives including pronutrients, mycotoxin binders, preservatives, enzymes, antioxidants, flavorings, and digestive products. Products are sold to distributors and directly to farms across poultry, swine, ruminants, aquaculture, and pets segments. Revenue generated through product sales with dosage-based consumption (e.g., 0.5 kg per ton of feed, 1 ml/L in drinking water).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Alquerfeed Antitox - Mycotoxin binder dosage |
| Unit Pricing | Pay-as-you-go | Immunostimulant Pronutrients - Drinking water application |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Biovet product offering
Product offeringCore offering
Biovet manufactures and sells natural feed additives for animal nutrition, including pronutrients (botanical extracts), mycotoxin binders, preservatives, enzymes, antioxidants, flavorings, and digestive additives. Products are organized across multiple animal segments (poultry, swine, ruminants, aquaculture, pets) and address intestinal health, mycotoxin control, coccidiosis prevention, ammonia reduction, and feed preservation. The company distributes through direct veterinary-led sales and a regional distributor network globally.
Product overview
Biovet S.A. is a manufacturer of natural additives for animal feed founded in 1984. The company offers a comprehensive portfolio of products organized by product lines (Pronutrients, Mycotoxin Binders, Preservatives, Digestives, Enzymes, Antioxidants, Flavorings, Nutritional, Multifunctionals, Pets, Fishing Line) and by animal species (Poultry, Pigs, Ruminants, Aquaculture, Pets). The core products include Alquerfeed Antitox (broad-spectrum mycotoxin binder using patented Silicoglycidol molecule), Alquermold Natural Plus (natural preservative with microbiocidal action), the Alquernat line of pronutrients (including Alquernat Zycox for coccidiosis, Alquernat Yucca for ammonia reduction, Alquernat Inmuplus for immune stimulation, Alquernat Nebsui for intestinal health), Alquerfeed Diatom for digestive efficiency, and various specialty products. The company emphasizes R&D collaboration with universities worldwide for product development and validation.
Differentiator
Problem solved
Functional benefit
Brands
- Alquerfeed Antitox: Broad-spectrum mycotoxin binder based on patented Silicoglycidol molecule, effective at 0.5 kg/t dosage
- Alquermold Natural Plus
- Alquernat Zycox
- Alquernat Nebsui
- Alquernat Yucca
- Alquerfeed Diatom / Alquerfeed Diatom AN
- Silicoglycidol
- Alquermold Natural
Quantifiable outcome
- 21% mortality reduction in broilers challenged with DON mycotoxin compared to control group
- +6 more outcomes
Companies that use Biovet
Customer profileNamed customers5 records
Segments6 records
Ideal customer profiles5 records
Biovet technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Biovet partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- University of Helsinki (Finland)coreBiovet collaborated with the University of Helsinki on in-vitro evaluation studies using a simulator of the gastrointestinal tract of birds. The 3-phase model replicates real digestive conditions (crop, gastric, intestinal phases) for testing mycotoxin binder efficacy and feed preservatives under controlled, reproducible conditions.
- Universidad Científica del Sur (Lima, Peru)coreUniversidad Científica del Sur conducted trials evaluating Alquermold Natural Plus for prevention and treatment of necrotic enteritis (Clostridium perfringens) in broilers. Study demonstrated product efficacy in improving performance parameters and reducing mortality under challenge conditions.
- European, US, and Asian UniversitiescoreBiovet has signed collaboration agreements with several universities in Europe, the United States and Asia for in-vitro tests. The company also works with biotechnological research institutes for development of innovative molecules.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Biovet competitors and assessment
Company assessmentBroad incumbents
- DSM-Firmenich (Biomin): Global animal nutrition major with a leading mycotoxin risk management portfolio (Mycofix, TOXO). Directly comparable to Biovet's Silicoglycidol-based mycotoxin binder business, but operating at vastly greater scale and breadth across species and geographies.
- Adisseo: Specialty animal nutrition company (part of Bluestar) providing feed additives including mycotoxin management, enzymes, and gut health solutions. Comparable to Biovet's Silicoglycidol and additive product lines, but with much larger global commercial footprint.
- Kemin Industries: Global ingredient manufacturer with animal nutrition division offering mold inhibitors, mycotoxin binders, and gut health products. Directly overlaps with Biovet's preservative (Cimenol ring) and mycotoxin binder product lines.
- Phibro Animal Health: Global animal health and nutrition company offering feed additives, vaccines, and specialty nutritional products. Comparable to Biovet's portfolio breadth across poultry, swine, and ruminants, with significantly greater commercial scale.
- Cargill Animal Nutrition: Global agribusiness major with a dedicated animal nutrition business offering premixes, additives, and mycotoxin management solutions. Comparable distribution channels and customer base to Biovet, with vastly greater resources and vertical integration.
Direct peers
- Alltech: Privately held global animal nutrition company offering mycotoxin binders (Mycosorb, Mycosorb A+), pronutrient-style natural additives, and gut health solutions. Closely comparable to Biovet's mycotoxin and intestinal health product portfolio across multiple species.
- Novus International: Animal nutrition and health company offering feed additives including organic acids, mycotoxin binders, and gut health solutions. Comparable product portfolio to Biovet, focused on swine and poultry production globally.
- Lallemand Animal Nutrition: Producer of probiotics, silage inoculants, and natural feed additives for livestock, poultry, and aquaculture. Comparable to Biovet's pronutrient and natural additive approach, with overlapping focus on antibiotic-free production.
- Olmix Group: Mid-sized animal nutrition company specializing in natural feed additives including mycotoxin binders (MT.X+), gut health, and immunity solutions based on algae and clay technologies. Comparable to Biovet's mycotoxin and natural additive positioning, though with broader algae-based focus.
Emerging players
- Innov Ad NV: Independent specialty feed additive company offering mycotoxin binders (Toxfin, Unike Plus), gut health solutions, and natural alternatives for antibiotic-free production. Comparable mid-tier peer to Biovet in product scope and size, with overlapping focus on natural feed additives.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Biovet social profiles
Digital presenceBiovet compliance and trust
Trust signalCompliance1 record
Biovet financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biovet leadership team
Management profileNumber of profiles
Profiles1 record
Biovet funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biovet M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biovet
What does Biovet do?
Biovet manufactures and sells natural feed additives for animal nutrition, including pronutrients (botanical extracts), mycotoxin binders, preservatives, enzymes, antioxidants, flavorings, and digestive additives. Products are organized across multiple animal segments (poultry, swine, ruminants, aquaculture, pets) and address intestinal health, mycotoxin control, coccidiosis prevention, ammonia reduction, and feed preservation. The company distributes through direct veterinary-led sales and a regional distributor network globally.
Is Biovet a public or private company?
Biovet is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biovet founded?
Biovet was founded in 1984. It employs 11 to 50 people.
Where is Biovet based?
Biovet is headquartered in Tarragona, Spain, in the Europe region.
How does Biovet make money?
One revenue line is on record: natural Feed Additives - Product Sales.
Who are Biovet's main competitors?
Broad incumbents on record are DSM-Firmenich (Biomin), Adisseo, Kemin Industries, Phibro Animal Health and Cargill Animal Nutrition. Direct peers are Alltech, Novus International, Lallemand Animal Nutrition and Olmix Group. Innov Ad NV is listed as an emerging player.
Does Biovet have an API?
No public API is recorded for Biovet.
What industry is Biovet in?
Biovet's product category is Animal Feed Additives. Its primary akta.pro industry code is AFADAKAG, Mycotoxin Risk Management (Binders, Deactivators), with a secondary code of AFADAMAF, Additive & Premix Integration Services (enzymes, probiotics, minerals/vitamins, medication where permitted). Its NAICS code is 311119 and its SIC code is 2000.